Influence of Diabetes on Cardiac Resynchronization Therapy With or Without Defibrillator in Patients With Advanced Heart Failure Jalal k. Ghali, MD,

Slides:

Advertisements

Similar presentations

Preoperative Evaluations: The Very Last Chance To Identify a Problem With a Pacemaker or Implanted Cardioverter-Defibrillator Marc A. Rozner, PhD, MD Journal.

Advertisements

CHA2DS2-VASC and CHADS2 Scores Predict Adverse Clinical Events in Patients With Pacemakers and Sinus Node Dysfunction Independent of Atrial Fibrillation

Comparison of Low Versus High (>40 mm Hg) Pulse Pressure to Predict the Benefit of Cardiac Resynchronization Therapy for Heart Failure (from the Multicenter.

Journal of Cardiac Failure

Identifying patients for advanced heart failure therapy by screening patients with cardiac resynchronization therapy or implantable cardioverter-defibrillator:

Utility of the Seattle Heart Failure Model in patients with cardiac resynchronization therapy and implantable cardioverter defibrillator referred for.

Michael J. Koren, MD, Michael H. Davidson, MD, Daniel J

Andrew Moran, MD, MPH, Ronit Katz, PhD, Nicolas L. Smith, PhD, Linda F

Higher Biologically Effective Dose of Radiotherapy Is Associated With Improved Outcomes for Locally Advanced Non–Small Cell Lung Carcinoma Treated With.

New-onset Atrial Fibrillation Predicts Heart Failure Progression

Prolonged Electrical Muscle Stimulation Exercise Improves Strength, Peak VO2, and Exercise Capacity in Patients With Stable Chronic Heart Failure Prithwish.

Risk of Heart Failure in Obese Patients With and Without Bariatric Surgery in Sweden— A Registry-Based Study Christina E. Persson, MMed, Lena Björck,

Rationale and design of a randomized clinical trial to assess the safety and efficacy of frequent optimization of cardiac resynchronization therapy: The.

Should paroxysmal atrial fibrillation be treated during cardiac surgery? Patrick M. McCarthy, MD, Adarsh Manjunath, BA, Jane Kruse, RN, BSN, Adin-Cristian.

Use of Hand Carried Ultrasound, B-type Natriuretic Peptide, and Clinical Assessment in Identifying Abnormal Left Ventricular Filling Pressures in Patients.

Renato D. Lopes, MD, PhD, Li Li, MS, Christopher B

Canadian Cardiovascular Society Guidelines on the Use of Cardiac Resynchronization Therapy: Implementation Ratika Parkash, MD, MSc, François Philippon,

Masaya Koshizaka, MD, PhD, Renato D. Lopes, MD, PhD, MHS, L

Volume 11, Issue 8, Pages (August 2014)

Impact of More Restrictive Blood Transfusion Strategies on Clinical Outcomes: A Meta- analysis and Systematic Review Shelley R. Salpeter, MD, Jacob S.

Preface Heart Failure Clinics

Prevalence, Predictors, and Outcomes in Treatment-resistant Hypertension in Patients with Coronary Disease Sripal Bangalore, MD, MHA, Rana Fayyad, PhD,

Samy Suissa, PhD, Abbas Kezouh, PhD, Pierre Ernst, MD, MSc

Trends in Comorbidity, Disability, and Polypharmacy in Heart Failure

Phosphorus and Risk of Renal Failure in Subjects with Normal Renal Function John J. Sim, MD, Simran K. Bhandari, MD, Ning Smith, PhD, Joanie Chung, MS,

Optimizing the Success of a Palliative Care Consult Service: How to Average Over 110 Consults Per Month Steven Radwany, MD, Hallie Mason, MSN, CRNP,

Leslie R. Harrold, MD, MPH, Daniel Peterson, MS, Ashley J

Sabina Hunziker, MD, MPH, Jennifer Stevens, MD, MS, Michael D

Repeated Heart Rate Measurement and Cardiovascular Outcomes in Left Ventricular Systolic Dysfunction Victoria Hamill, PhD, Ian Ford, PhD, Kim Fox, MD,

Minimally Invasive Versus Sternotomy Approach for Mitral Valve Surgery in Patients Greater Than 70 Years Old: A Propensity-Matched Comparison David M.

Laura Boucai, MD, MS, William N

Rate-control versus Rhythm-control Strategies and Outcomes in Septuagenarians with Atrial Fibrillation Nasir Shariff, MD, Ravi V. Desai, MD, Kanan Patel,

Vitamin D deficiency in patients with chronic and acute urticaria: A systematic review and meta-analysis Tsung-Yu Tsai, MD, Yu-Chen Huang, MD Journal.

Clinical factors associated with long-term mortality following vascular surgery: Outcomes from The Coronary Artery Revascularization Prophylaxis (CARP)

Dual antiplatelet therapy is associated with prolonged survival after lower extremity revascularization Peter A. Soden, MD, Sara L. Zettervall, MD, MPH,

Michael L. Bailey, MBBS, Sven M. Richter, MD, Daniel V

Impact of Preoperative Angiotensin-Converting Enzyme Inhibitor Use on Clinical Outcomes After Cardiac Surgery Maral Ouzounian, MD, Karen J. Buth, MS,

Interaction of Physical Activity and Body Mass Index on Mortality in Coronary Heart Disease: Data from the Nord-Trøndelag Health Study Trine Moholdt,

Molly E. Waring, PhD, Jane S

Todd R. Vogel, MD, MPH, Viktor Y. Dombrovskiy, MD, PhD, MPH, Paul B

Should paroxysmal atrial fibrillation be treated during cardiac surgery? Patrick M. McCarthy, MD, Adarsh Manjunath, BA, Jane Kruse, RN, BSN, Adin-Cristian.

Volume 9, Issue 1, Pages (January 2012)

Alik Farber, MD, Tze-Woei Tan, MD, Denis Rybin, MS, Jeffrey A

Ethnic and racial disparities in cardiac resynchronization therapy

Volume 14, Issue 12, Pages (December 2017)

Effect of Intensive Insulin Therapy and Pentastarch Resuscitation on Acute Kidney Injury in Severe Sepsis George Thomas, MD, MPH, Ethan M. Balk, MD,

Reshma P. Duffy, MD, Julie E. Adams, MD, Peter W

Volume 7, Issue 7, Pages (July 2010)

Volume 14, Issue 12, Pages (December 2017)

Volume 9, Issue 8, Pages S14-S17 (August 2012)

In-hospital and 30-day outcomes after tibioperoneal interventions in the US Medicare population with critical limb ischemia Todd R. Vogel, MD, MPH, Viktor.

Right ventricular failure after cardiac surgery: Why can't right ventricular assist device support fix the problem? Francis D. Pagani, MD, PhD The Journal.

Dual antiplatelet therapy (clopidogrel and aspirin) is associated with increased all-cause mortality after carotid revascularization for asymptomatic.

Effects of diabetes on small aortic aneurysms under surveillance according to a subgroup analysis from a randomized trial Paola De Rango, MD, PhD, Piergiorgio.

Anne L. M. Vlek, MD, Yolanda van der Graaf, MD, PhD, Maayke A

Study Designs in Patient-Oriented Research

Gopi Dandamudi, MD Cardiac Electrophysiology Clinics

Volume 25, Issue 4, Pages xi-xiii (November 2007)

Shannon M. Dunlay, MD, MS, Quinn R. Pack, MD, Randal J

Prevalence and Risk Factors for Erectile Dysfunction in the US

Figure 1 Cumulative late adjusted survival in cardiac resynchronization therapy defibrillator and pacemaker patients. ... Figure 1 Cumulative late adjusted.

Nilay S. Shah, MD, MPH, David Leonard, PhD, Carrie E

Seasonal patterns in alopecia areata, totalis, and universalis

Speed of Finger Tapping as a Predictor of Functional Outcome After Unilateral Stroke Danielle de Groot-Driessen, MD, Peter van de Sande, MSc, Caroline.

The future of cardiac surgery training: A survival guide

Outcomes of rehabilitation services for nursing home residents 12

Jeffrey Senfield et al. JACEP 2017;3:

Optimal timing for heart transplantation in patients bridged with left ventricular assist devices: Is timing of the essence? Chase R. Brown, MD, Fabliha.

Volume 16, Issue 7, Pages (July 2019)

Volume 16, Issue 6, Pages (June 2019)

Presentation transcript:

Influence of Diabetes on Cardiac Resynchronization Therapy With or Without Defibrillator in Patients With Advanced Heart Failure Jalal k. Ghali, MD, John Boehmer, MD, Arthur M. Feldman, MD, PhD, Leslie A. Saxon, MD, Teresa Demarco, MD, Peter Carson, MD, Patrick Yong, MSEE, Elizabeth G. Galle, MS, Jill Leigh, BS, Fred L. Ecklund, MS, Michael R. Bristow, MD, PhD Journal of Cardiac Failure Volume 13, Issue 9, Pages 769-773 (November 2007) DOI: 10.1016/j.cardfail.2007.06.723 Copyright © 2007 Elsevier Inc. Terms and Conditions

Fig. 1 Effect of diabetes status on outcome. HR, hazard ratio; CI, confidence interval; OPT, optimal pharmacologic therapy; CRT, cardiac resynchronization therapy. Journal of Cardiac Failure 2007 13, 769-773DOI: (10.1016/j.cardfail.2007.06.723) Copyright © 2007 Elsevier Inc. Terms and Conditions

Fig. 2 Effect of CRT on outcomes in diabetic patients. CRT, cardiac resynchronization therapy; OPT, optimal pharmacologic therapy; HR, hazard ratio; CI, confidence interval. Journal of Cardiac Failure 2007 13, 769-773DOI: (10.1016/j.cardfail.2007.06.723) Copyright © 2007 Elsevier Inc. Terms and Conditions